08-Jul-2026 13:11:23
SUVENIPO
SUVEN LIFE SCIENCES LIMITED RAISED RS 248.84 CR FUNDS FROM QIB @ ₹134/SHARE
• Allotment of 1,85,70,133 equity shares on preferential basis upon conversion of fully paid warrants. • Total consideration aggregated ₹248,83,97,822/- • Re-appointment of Dr. Vajja Sambasiva Rao as Non-Executive Independent Director for a second term of 5 years w.e.f. January 21, 2027. • Incorporation of a Wholly owned Subsidiary (WOS) in Singapore: Suven Neurosciences Pte. Ltd.
Suven Life Sciences Limited
Open attachment